MDPI and ACS Style
Auguet, T.; Lopez-Dupla, M.; Ramos, J.; Bertran, L.; Riesco, D.; Aguilar, C.; Ardévol, A.; Pinent, M.; Sabench, F.; Del Castillo, D.;
et al. Lipocalin, Resistin and Gut Microbiota-Derived Propionate Could Be Used to Predict Metabolic Bariatric Surgery Selected Outcomes. Processes 2022, 10, 143.
https://doi.org/10.3390/pr10010143
AMA Style
Auguet T, Lopez-Dupla M, Ramos J, Bertran L, Riesco D, Aguilar C, Ardévol A, Pinent M, Sabench F, Del Castillo D,
et al. Lipocalin, Resistin and Gut Microbiota-Derived Propionate Could Be Used to Predict Metabolic Bariatric Surgery Selected Outcomes. Processes. 2022; 10(1):143.
https://doi.org/10.3390/pr10010143
Chicago/Turabian Style
Auguet, Teresa, Miguel Lopez-Dupla, Jessica Ramos, Laia Bertran, David Riesco, Carmen Aguilar, Anna Ardévol, Montserrat Pinent, Fà tima Sabench, Daniel Del Castillo,
and et al. 2022. "Lipocalin, Resistin and Gut Microbiota-Derived Propionate Could Be Used to Predict Metabolic Bariatric Surgery Selected Outcomes" Processes 10, no. 1: 143.
https://doi.org/10.3390/pr10010143